Menard Financial Group’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,165
Closed -$16K 236
2024
Q4
$16K Buy
+1,165
New +$16K 0.01% 219